BrightFocus Foundation
BrightFocus Foundation

Whole Exome Sequencing in Age-Related Macular Degeneration

Principal Investigator

Co-Principal Investigator

Project Goals

Despite recent success finding common genetic variations that influence risk of developing AMD, many causes remain to be identified. One under-studied area is the role of rare genetic variation in determining risk of developing AMD, and recent technological advances have enabled large-scale DNA sequencing efforts to find these rare variations. We seek to understand the role of rare genetic variations in determining risk for AMD by examining a set of individuals with advanced AMD but none of the known genetic risk factors, and a set of individuals without AMD at an older age despite having one or more of the known genetic factors.

Project Summary

There are many genes that are linked to the risk of developing age‐related macular degeneration (AMD), but there is still room to discover more. In this proposed project, Drs. Margaret Pericak‐Vance, William Scott, and colleagues will study the DNA of two groups of people that should increase their chances of finding new risk genes. One group has advanced AMD despite not having any of the known risk variants in the genes associated with AMD risk (including CFH and ARMS2) and the other group doesn’t have AMD despite having known risk variants in these genes. These researchers will use new gene reading techniques to look at the “whole exome” or the DNA spelling of the most‐used books in a person’s genetic library. Cataloguing the gene changes in both sets of people with AMD will lead to better understanding of how this disease starts and give clues to future preventions and treatments.

Progress Updates

Dr. Pericak-Vance’s and Dr. Scott’s team has competed 100% of the experiments designed for year 1 of this project. Whole exome sequencing (WES) has been successfully completed for four Amish families with suspected inherited AMD (a total of 15 individuals) and for 40 individuals of Caucasian descent with “sporadic” AMD (where there are no other reported cases of AMD in their family) and control healthy individuals. Findings from the four Amish families were analyzed with bioinformatics computer programs, and had their sequences confirmed/validated through a second method. A total of 26 genetic changes or “rare variants” (17 novel and 9 known) were identified. In the future, these rare variants will be checked for their presence in the DNA from a larger group of individuals with AMD.

Publications

D’Aoust L, Hoffman J, Cummings Ac, Agarwal A, Brantley MA, Kovach JL, Schwartz SG, Scott WK, Pericak-Vance MA, Haines JL. Genome-Wide Study for Age-related Macular Degeneration in the Amish. Poster Presentation at 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, Florida, May 5-10, 2012. (3301/A446).

Ayala-Haedo JA, Scott WK, Cade W, Gallins PJ, Agarwal A, Schwartz SG, Kovach JL, Wang G, Haines JL. Pericak-Vance MA. Exome Sequencing in Multiplex AMD Families. Poster Presentation at 2011 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, Florida, May 1-5, 2011. (#5224/D1108)

First published on: July 06, 2011

Last modified on: September 20, 2024